Please try another search
Indies Pharma Jamaica Limited reported earnings results for the first quarter ended January 31, 2024. For the first quarter, the company reported sales was JMD 269.38 million compared to JMD 255.64 million a year ago. Net income was JMD 62.49 million compared to JMD 59.03 million a year ago. Basic earnings per share from continuing operations was JMD 0.047 compared to JMD 0.045 a year ago.
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Total Revenue | 269.38 | 268.56 | 299.74 | 231.52 |
Gross Profit | 189.49 | 83.51 | 215.45 | 163.82 |
Operating Income | 85.89 | 48.57 | 98.38 | 45.68 |
Net Income | 62.49 | 39.85 | 84.29 | 28.36 |
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Total Assets | 2294.34 | 2240.19 | 2164.39 | 2245.44 |
Total Liabilities | 1012.81 | 1021.15 | 981.69 | 1150.39 |
Total Equity | 1281.53 | 1219.04 | 1182.69 | 1095.06 |
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -14.37 | 27.41 | 158.49 | 11.29 |
Cash From Investing Activities | -4.46 | 89.64 | 10 | 8.29 |
Cash From Financing Activities | -20.44 | -115.65 | -180.15 | -39.29 |
Net Change in Cash | -39.27 | 1.85 | -11.65 | -19.71 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review